Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 a » 10 _ (Expand Search), 10 μ (Expand Search), 1 a (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 a » 10 _ (Expand Search), 10 μ (Expand Search), 1 a (Expand Search)
-
8741
-
8742
-
8743
-
8744
-
8745
-
8746
-
8747
-
8748
-
8749
-
8750
-
8751
-
8752
-
8753
-
8754
-
8755
-
8756
-
8757
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes with Alirocumab: Post-Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial
Published 2025“…<a href="" target="_blank">OR for NOD for 25% and 50% lipoprotein(a) reductions were 1.12 (95% CI 1.01</a>-1.23) and 1.24 (1.02-1.52). …”
-
8758
-
8759
-
8760